MYD88 is a downstream mediator following Toll-like receptor activation, the mRNA of which was reported to be over-expressed in CD34+ cells of low-risk MDS compared to healthy donors in previous investigation, inhibition of which restored erythroid colony formatting capacity of HSPC. This evidence concerns the gene MYD88 and myelodysplastic syndrome.